Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Percent of class outstanding is based on a total of 5,203,290 shares of common stock outstanding, as reported in the Issuer's final prospectus filed with the Securities and Exchange Commission on Decmeber 11, 2025 (including 1,815,049 shares of common stock issuable upon the exercise of the Pre- Funded Warrants held by the selling stockholders).


SCHEDULE 13G




Comment for Type of Reporting Person:  Percent of class outstanding is based on a total of 5,203,290 shares of common stock outstanding, as reported in the Issuer's final prospectus filed with the Securities and Exchange Commission on Decmeber 11, 2025 (including 1,815,049 shares of common stock issuable upon the exercise of the Pre- Funded Warrants held by the selling stockholders).


SCHEDULE 13G



 
Pfizer Inc. (IRS Identification No.: 13-5315170)
 
Signature:/s/ Madelyn D. Purcell
Name/Title:Madelyn D. Purcell/Assistant Secretary
Date:02/13/2026
 
Pfizer Ventures (US) LLC (IRS Indentification No. 82-5524518 )
 
Signature:/s/ Esther Louis
Name/Title:Esther Louis/ Secretary
Date:02/13/2026